Cell Therapy Approaches Show Early Promise Against Alzheimer’s

Cell therapy approaches are showing genuinely promising results against Alzheimer's disease, with recent clinical trials demonstrating measurable...

Cell therapy approaches are showing genuinely promising results against Alzheimer's disease, with recent clinical trials demonstrating measurable...

On March 25, 2026, Anavex Life Sciences withdrew its European Union marketing authorization application for blarcamesine—a potential early Alzheimer's...

Support programs provide Alzheimer's caregivers with practical tools, emotional relief, and specialized guidance to manage the physical and psychological...

Yes, approved Alzheimer's treatments demonstrably slow cognitive decline in early-stage disease, with clinical evidence showing patients can delay...

Technology solutions are fundamentally reshaping how healthcare systems detect and diagnose Alzheimer's disease and related dementias.

Integrated healthcare models—where primary care physicians, neurologists, social workers, and care coordinators work together as one team—do meaningfully...

Yes, brief wellness practices meaningfully support brain health and can help slow cognitive decline over time.

Biomarker technology is fundamentally reshaping how Alzheimer's clinical trials are designed and executed.

Real-world evidence programs monitor Alzheimer's treatment outcomes by collecting clinical and safety data on FDA-approved therapies in actual patient...

Patient safety advocates are pushing healthcare systems to adopt stricter clinical protocols, better training requirements for dementia care staff, and...
HelpDementia.com
Dementia, Alzheimer's, Caregiving & Healthy Aging Guidance
© 2026 HelpDementia.com. All rights reserved.
Educational information only. It is not medical advice and does not replace care from a qualified clinician.